| Heather Masse, APRN | |
|
16230 Summerlin Rd, Suite 215, Fort Myers, FL 33908-5768 | |
| (239) 343-6050 | |
| (239) 343-6136 |
| Full Name | Heather Masse |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 16230 Summerlin Rd, Fort Myers, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790161248 | NPI | - | NPPES |
| 015446500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | APRN9200432 (Florida) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APRN9200432 (Florida) | Primary |
| Entity Name | Lee Memorial Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992873319 PECOS PAC ID: 8729996608 Enrollment ID: O20031118000604 |
News Archive
This May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury Associations worldwide in their effort to spread Multiple Chemical Sensitivity Syndrome awareness
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
A rare autoimmune disease creates sudden pain in the abdomen or the head, sending a patient to the emergency room with a potentially fatal condition. The pain comes from a multitude of blockages of tiny blood vessels, formed after the patient's own immune system somehow inhibits an enzyme that is vital to control clotting.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Masse, APRN Po Box 2147, Fort Myers, FL 33902-2147 Ph: (239) 343-6050 | Heather Masse, APRN 16230 Summerlin Rd, Suite 215, Fort Myers, FL 33908-5768 Ph: (239) 343-6050 |
News Archive
This May, AllerAir is supporting Multiple Chemical Sensitivities and Chemical Injury Associations worldwide in their effort to spread Multiple Chemical Sensitivity Syndrome awareness
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
When it comes to an addictive disorder, you either have it or you don't. But this dichotomous nature of the diagnosis fails to recognize the complexity and diversity of addiction's origins and manifestation in people.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
A rare autoimmune disease creates sudden pain in the abdomen or the head, sending a patient to the emergency room with a potentially fatal condition. The pain comes from a multitude of blockages of tiny blood vessels, formed after the patient's own immune system somehow inhibits an enzyme that is vital to control clotting.
› Verified 6 days ago
Dr. Otniel Hernandez, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3677 Central Ave Ste B, Fort Myers, FL 33901 Phone: 239-790-1263 Fax: 239-790-1074 | |
Pamela Lynn Cooper, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12734 Kenwood Ln, Suite 84, Fort Myers, FL 33907 Phone: 866-936-5250 | |
April Stewart Stowers, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13782 Plantation Rd Ste 201, Fort Myers, FL 33912 Phone: 239-343-1100 Fax: 239-343-1101 | |
Carmalee Martin, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9341 Via San Giovani St, Fort Myers, FL 33905 Phone: 249-297-4864 | |
Sarah Elizabeth Long, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9241 Park Royal Dr, Fort Myers, FL 33908 Phone: 239-985-2700 | |
Ms. Susan Ann Sherman, MS, ARNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3900 Broadway, Suite B-1, Fort Myers, FL 33901 Phone: 239-939-2808 Fax: 239-939-4794 | |
Tracy Heather Zielinski, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4219 Lemongrass Dr, Fort Myers, FL 33916 Phone: 239-272-7705 |